Christine Årdal is a senior researcher at the Norwegian Institute of Public Health (NIPH) with a focus on the policy aspects of medicine access and innovation, particularly antibiotics.

She has worked for over 25 years on access to medicines through different sectors, including research institutes, governmental development assistance, pharmacy, national health service and insurance. Christine was a co-lead in the DRIVE-AB research project which aimed to transform the way policymakers stimulate innovation, sustainable use, and the equitable availability of novel antibiotics to meet unmet public health needs. She was also the co-lead of the research and innovation work package for the European Union’s Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI).

Christine also works on accessibility to medicines generally through the Oslo Medicines Initiative and the World Health Organization expert review panel for the overall programme review of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property. She led the Norwegian Agency for Development Cooperation’s (Norad) efforts within the UN Commission on Life-Saving Commodities for Women and Children.